Repurposing drugs for a pan-coronavirus treatment

(European Molecular Biology Laboratory - European Bioinformatics Institute) The study identifies drug targets common to all three coronaviruses (SARS-CoV-2, SARS-CoV-1, and MERS-CoV) and potential drugs that could be repurposed as COVID-19 treatments. The researchers suggest that repurposed pan-coronavirus therapeutics may offer a rapid treatment response against future emerging coronavirus strains
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news